tiprankstipranks
Immunotech Biopharm Ltd (HK:6978)
:6978
Hong Kong Market
6978
Immunotech Biopharm Ltd
RESEARCH TOOLSreports
Want to see HK:6978 full AI Analyst Report?

Immunotech Biopharm Ltd (6978) Income Statement

1 Followers

Immunotech Biopharm Ltd Income Statement

Last quarter (Q4 2025), Immunotech Biopharm Ltd's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q4, Immunotech Biopharm Ltd's net income was ¥-99.99M. See Immunotech Biopharm Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ -53.87M¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Expenses
¥ 115.49M¥ 198.78M¥ 230.55M¥ 273.93M¥ 344.86M
Depreciation and Amortization
¥ 53.87M¥ 52.22M¥ 52.22M¥ 43.11M¥ 21.00M
EBITDA
¥ -115.49M¥ -148.68M¥ -178.83M¥ -231.11M¥ -324.33M
Operating Income
¥ -169.36M¥ -198.78M¥ -230.55M¥ -273.93M¥ -344.86M
Other Income/Expenses
¥ -55.57M¥ 12.36M¥ -104.93M¥ -47.16M¥ -9.75M
Pretax Income
¥ -224.93M¥ -186.42M¥ -335.48M¥ -321.10M¥ -354.62M
Net Income
¥ -224.81M¥ -186.91M¥ -334.82M¥ -318.11M¥ -354.22M
Per Share Metrics
Basic EPS
¥ -0.41¥ -0.36¥ -0.65¥ -0.62¥ -0.69
Diluted EPS
¥ -0.41¥ -0.36¥ -0.65¥ -0.62¥ -0.69
Weighted Average Shares Outstanding
 549.00M 514.58M 514.58M 514.58M 514.58M
Weighted Average Shares Outstanding (Diluted)
 549.00M 514.58M 514.58M 514.58M 514.58M
Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History